Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,239
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
for
Familial Adenomatous Polyposis
Location: Nashville TN, St Louis MO, Dallas TX, Philadelphia PA,
Sponsor: Recursion Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT05552755
Phase 1, Phase 2, Recruiting
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
for
Parkinson's Disease
Location: Nashville TN, Birmingham AL, Chicago IL,
Sponsor: Intec Pharma Ltd.
Sex: All
Age: 30 - 70+
Code: NCT02615873
Phase 3, Recruiting
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
for
Phenylketonuria (PKU)
Location: Nashville TN, Atlanta GA, Indianapolis IN, Chicago IL,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 0+
Code: NCT06305234
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
for
Intestinal Failure Associated Liver Disease
Location: Nashville TN, Atlanta GA, Chicago IL, Durham NC,
Sponsor: NorthSea Therapeutics B.V.
Sex: All
Age: 16+
Code: NCT05919680
Phase 2, Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
for
Phenylketonuria (PKU)
Location: Nashville TN, Atlanta GA, Indianapolis IN, Chicago IL,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 0+
Code: NCT05813678
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
for
Ewing Sarcoma, Colorectal Adenocarcinoma
Location: Nashville TN, Atlanta GA, Cincinnati OH,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 12 - 70+
Code: NCT03715933
Phase 1, Recruiting
A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations
for
Advanced Solid Tumors With MAPK Pathway Mutations
Location: Nashville TN, Detroit MI, Houston TX
Sponsor: D3 Bio (Wuxi) Co., Ltd
Sex: All
Age: 18+
Code: NCT05886920
Phase 1, Phase 2, Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Nashville TN, Birmingham AL, Louisville KY, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Location: Nashville TN, Lexington KY, St Louis MO, Columbus OH,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT07165132
Phase 1, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Nashville TN, Louisville KY, Atlanta GA, Newnan GA,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase 3, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Nashville TN, Louisville KY, Atlanta GA, Snellville GA,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase 3, Recruiting
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Nashville TN, St Louis MO, Cleveland OH, Detroit MI,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07081646
Phase 1, Phase 2, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: Nashville TN, Atlanta GA, Lexington KY, Greenville SC,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase 3, Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function